Home › Therapeutic areas › Metabolic › Type 1 Diabetes

Type 1 Diabetes (9 companies)

Companies with an active program in Type 1 Diabetes.

Ticker Company Therapeutic areas Programs Lead stage Mkt cap Programs
IPSC Century Therapeutics ImmunologyMetabolic+1 Rare 1 Phase 1 $249M 9
ELDN Eledon Pharmaceuticals ImmunologyMetabolic+1 Rare 1 Phase 2 $167M 3
IMCR Immunocore DermatologyInfectious Disease+2 1 Approved $1.44B 12
KURA Kura Oncology MetabolicOncology 1 Approved $688M 13
LCTX Lineage Cell Therapeutics MetabolicNeurology+1 Rare 1 Phase 2 $207M 13
NKTR Nektar Therapeutics DermatologyImmunology+2 1 Phase 3 $1.23B 11
SABS SAB Biotherapeutics Metabolic 1 Phase 2 $266M 1
SANA Sana Biotechnology MetabolicOncology 2 Phase 1 $563M 4
VTVT vTv Therapeutics HematologyMetabolic+1 Rare 2 Phase 3 $69.4M 9